HOME >> MEDICINE >> NEWS
Rockefeller University researchers are changing the face of drug addiction treatment

dea of operant conditioning, which proposes that behavior is more likely to continue if it is reinforced. In the mid-70's, Maxine Stitzer, Ph.D., from Johns Hopkins University and a co-author of this paper, began to test the effectiveness of this theory and intervention method on patients addicted to drugs.

"There was a debate between the scientific and the traditional worlds of drug treatment," says Kellogg. "At first, the traditionalists were not able to take in a behavioral perspective as they saw addiction as an innate disease; therefore external circumstances should not affect an addicted person's behavior. But those ideas are changing now, and that change is part of our story."

The National Institute of Drug Addiction (NIDA) developed the Clinical Trials Network to both test and publicize various science-based addiction treatments, and the contingency management program was one of the first chosen to study. At a conference sponsored by NIDA, Kellogg, who is the scientific director for the contingency management intervention in New York, met Peter Coleman and Marylee Burns, from the Office of Behavioral Health at the HHC, who are contributing authors to the paper. Their meeting produced one of the largest adoptions ever done of contingency management, which involved five addiction clinics in New York City.

"The Health and Hospitals Corporation was already preparing to apply something similar to the contingency management approach," Kellogg says. "They were thinking of giving people rewards when they reached significant treatment benchmarks, such as holding a job for six months. Using the science of operant conditioning, we suggested to them that you could achieve a better outcome if you don't simply reward the attainment of goals, but, instead, you reinforce all of the steps along the way."

"Scott developed the concept of a modified, practical but formal contingency management intervention within a community-based treatment sett
'"/>

Contact: Kristine Kelly
kkelly@rockefeller.edu
212-327-7146
Rockefeller University
1-Apr-2005


Page: 1 2 3

Related medicine news :

1. Rockefeller Foundation will not abandon its commitments to public health
2. Indiana University Imaging Center receives $6M grant for kidney research
3. University hospitals wins multiple national IT awards for electronic patient data bank
4. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
5. University research wins royal accolade
6. New Orleans levee report finished by panel including University of Texas at Austin engineer
7. Boston University School of Medicine faculty member receives honorary degree from alma mater
8. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
9. Emory University researchers find persistent and severe asthma associated with obesity
10. Mid Sweden University leads development of digital color x-rays
11. $2.6M grant awarded to New York University College of Nursing

Post Your Comments:
(Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
(Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
(Date:1/23/2015)... Fla. , Jan. 23, 2015  HyGreen, Inc., a ... agreement and partnership with RCA Medical, a subsidiary of ... . Each year, hundreds of millions ... care-associated infections as organisms are transmitted from patient to ...
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
Cached News: